NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/11/2025
Voltar para busca
Dado oficial do USPTO
SEER CLOUD
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
08/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9
Data de depósito
07/10/2021
Data de registro
01/10/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/10/2024
Última transação
08/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
81
Localização do titular
AU
Examinador
STADELI,MARTA ANN
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Seer Medical Holdings Limited
Seer Medical Pty Ltd
Representantes
JOHN C. MCELWAINE NELSON MULLINS RILEY & SCARBOROUGH LLP
Classificação técnica
Classes Nice
Classe 9
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable computer programs for medical purposes for diagnosismonitoringmanagement and treatment of neurological conditions; downloadable computer programs for health purposes for diagnosismonitoringmanagement and treatment of neurological conditions; downloadable computer application software for use in the provision of and access to medical treatment relating to neurological and cardiac conditions and sleep disorders; downloadable computer application software for the provision of diagnostic medical and health information for use in body monitoring relating to neurological and cardiac conditions and sleep disorders including the management of epilepsyheart and sleep disorder; downloadable computer application software for recordingcollectionorganisationmanagement and transmission of medical and health information relating to neurological and cardiac conditions and sleep disorders; downloadable software for use with medical devices for diagnosismonitoringmanagement and treatment of neurological conditions; downloadable software for use with medical diagnostic devices for diagnosismonitoringmanagement and treatment of neurological conditions; downloadable software for use with health monitoring devices for diagnosismonitoringmanagement and treatment of neurological conditions; downloadable software for use in the treatment of epilepsy for monitoring and diagnosing neurological diseases; downloadable software for use in the management of epilepsy for monitoring and diagnosing neurological diseases; downloadable electronic publications in the nature of scientific and medical research journal articles in the field of medical treatment for neurological and cardiac conditions and sleep disorders; downloadable electronic publications in the nature of scientific and medical research journal articles for providing information to patients and doctors in relation to epilepsy and other neurological conditions and the diagnosismonitoringmanagement and treatment thereof; downloadable computer database programs relating to medical and health information for diagnosismonitoringmanagement and treatment of neurological conditions; none of the foregoing in relation to reagentssoftware or hardware for the analysis of proteinsproteomesbiological datagoods and services in the fields of biomoleculesmetabolomicslipidomicsgenomicsepigenomicsproteomicstranscriptomicssecretomics
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
19/04/2025
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
04/03/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
04/03/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/01/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/10/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/10/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/10/2024
TMBN
TTAB RELEASE CASE TO TRADEMARKS
22/08/2024
OP.T
OPPOSITION TERMINATED NO. 999999
22/08/2024
OP.D
OPPOSITION DISMISSED NO. 999999
22/08/2024
RFNT
REFUSAL PROCESSED BY IB
01/05/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
19/04/2023
OP.I
OPPOSITION INSTITUTED NO. 999999
03/04/2023
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
31/03/2023
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
31/03/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/03/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
29/03/2023
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
03/11/2022
PUBO
PUBLISHED FOR OPPOSITION
04/10/2022
GPNX
NOTIFICATION PROCESSED BY IB
03/10/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
14/09/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
14/09/2022
NPUB
NOTICE OF PUBLICATION
14/09/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/08/2022
DMCC
DATA MODIFICATION COMPLETED
29/08/2022
ALIE
ASSIGNED TO LIE
29/08/2022
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
25/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/07/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/07/2022
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
08/05/2022
RFNT
REFUSAL PROCESSED BY IB
30/01/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/01/2022
RFRR
REFUSAL PROCESSED BY MPU
12/01/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/12/2021
CNRT
NON-FINAL ACTION WRITTEN
17/12/2021
DOCK
ASSIGNED TO EXAMINER
07/12/2021
MAFR
APPLICATION FILING RECEIPT MAILED
05/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/11/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/10/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SEER CLOUD ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.